jCyte Blog

General topics and announcements about jCyte and Retinitis Pigmentosa.


Lighting the Way to a Cure for Retinal Degeneration

Cells of the retina, which detect light from the back of the eye, are a part of the central nervous system (CNS). Unlike other parts of the body, the CNS cannot heal itself once it is damaged by injury or disease. This makes degenerative eye diseases like retinitis pigmentosa (RP)—a genetic disorder that causes progressive damage to retinal cells—incurable. RP can cause blindness, and symptoms typically begin to appear during adolescence.


Retinitis Pigmentosa Research News

The team remains hard at work on multiple preclinical projects, all due to be completed this year. The results of these critical translational studies will […]


Advancing Towards Clinical Trials

The team remains hard at work in our effort to bring retinal progenitor cells to clinical trials. The work being conducted now is centered on accumulating […]


Preparing for a New Drug Application

The past two months have been very active. We have begun final preparations to launch the formal research studies for our upcoming FDA application to […]


Next Steps for Patient Enrollment

Many people impacted by retinal degeneration are eager to hear updates on our upcoming clinical trial to test retinal progenitor cells as a treatment for retinitis pigmentosa. […]


Advancing our RP Treatment

This is our first update, and I want to acknowledge and thank those who have provided encouragement and positive feedback. The RP disease team successfully […]